Featured Case Study
Reduce Process Variability
A leading Pharmaceutical company was struggling with process variability in a complex step in their manufacturing process of a product that generated $3B of revenue annually. This variability led regulatory inspectors to question the company’s specification limits and their ability to manufacture the product reliably.
Human Genome Sciences: Aegis Discoverant for Emerging Biotechnology Companies
Human Genome Sciences (HGS) is committed to solving critical medical challenges through careful planning, relentless resilience, the best scientific minds, and rigorous clinical trials. For the company, success comes by design – and by working systematically to achieve breakthrough results one careful step at a time. HGS’ manufacturing and process development capability represents a significant strategic advantage. The company is able to produce and purify multiple protein and antibody drugs in two state-of-the-art process development and manufacturing facilities – totaling approximately 400,000 square feet and offering both small-scale and large-scale production. Read Case Study.